Patient Address Communication Language Race / Ethnicity

Transcription

1

2 Jianhua Draco Xie Continuity of Care Document, generated on Apr. 27, 2017 Patient Demographics - Male, born Sep. 16, 2012 Patient Address Communication Language Race / Ethnicity English (Preferred) Asian / Not Hispanic or Latino Note from Oregon Health & Science University This document contains information that was shared with Yong Xie. It may not contain the entire record from Oregon Health & Science University. Encounters - as of 04/27/2017 Date Type Specialty Care Team 02/09/2015 Office Visit Pediatric Gastroenterology Eroglu, Yasemen, MD 10/21/2014 Office Visit Pediatric Gastroenterology Eroglu, Yasemen, MD Allergies - as of 04/27/2017 No Known Allergies Medications - as of 04/27/2017 Prescription Sig. Disp. Start Date End Date Status PEDI MULTIVIT Take 2 ml by mouth once daily. Active #40/PHYTONADIONE (AQUADEKS PEDIATRIC ORAL) CALCIUM CARBONATE/VITAMIN Take 0.4 ml by mouth once Active D3 (VITAMIN D-3 ORAL) daily. Calcium 500 mg oral tablet Take 500 mg by mouth once daily. Active Active Problems - as of 04/27/2017 No known active problems Social History - as of 04/27/2017 Smoking Status as of 02/09/2015 Tobacco Use Types Packs/Day Years Used Date Never Smoker Smokeless Tobacco: Never Used Smoking Status as of 10/21/2014 Tobacco Use Types Packs/Day Years Used Date Never Smoker Last Filed Vital Signs - as of 04/27/2017 Vital Sign Reading Time Taken Pressure - - Pulse /21/2014 2:42 PM PDT Temperature - - Respiratory Rate 32 10/21/2014 2:42 PM PDT

3 Oxygen Saturation - - Inhaled Oxygen Concentration - - Weight 13.7 kg (30 lb 3.3 oz) 02/09/2015 1:34 PM PST Height 86.9 cm (2' 10.21") 02/09/2015 1:34 PM PST Body Mass Index /09/2015 1:34 PM PST Plan of Treatment - as of 04/27/2017 Not on file Results - as of 04/27/2017 RBC MORPHOLOGY - Final result (02/09/2015 3:40 PM) ANISOCYTOSIS 1+(10-25cells/HPF) MICROCYTOSIS 1+(10-25cells/HPF) CBC AND AUTO DIFF - Final result (02/09/2015 3:40 PM) WHITE CELL COUNT K/cu mm RED CELL COUNT M/cu mm HEMOGLOBIN g/dl HEMATOCRIT % MCV fl MCHC g/dl RDW SD fl PLATELET COUNT K/cu mm MPV fl NRBC% % NRBC# K/cu mm MANUAL DIFFERENTIAL - Final result (02/09/2015 3:40 PM) NEUTROPHIL % % LYMPHOCYTE % % MONOCYTE % % EOSINOPHIL % % BASOPHIL % % IMMATURE GRANULOCYTE% % REACTIVE LYMPHS % % NEUTROPHIL # K/cu mm

4 LYMPHOCYTE # K/cu mm MONOCYTE # K/cu mm EOSINOPHIL # K/cu mm BASOPHIL # K/cu mm IMMATURE GRANULOCYTE# K/cu mm REACTIVE LYMPHS # 1.07 K/cu mm Immature Granulocytes (IG) include metamyelocytes, myelocytes and promyelocytes. included in the IG count. Bands are included in the neutrophil count. Bands are not LAB OTHER - Final result (02/09/2015 3:40 PM) MISC REF TEST NAME Shwachman Diamond Syndrome (SBDS), WB EDTA MISC REF TEST RESULT Negative NORMAL RANGE REFERRAL LAB NAME Test performed by: Gene Dx 207 Perry Parkway Gaithersburg, Md OHSU REFERENCE LAB See scanned report for Technical Results and further Interpretation and Comments. INR - Final result (02/09/2015 3:40 PM) INR INR INR Therapeutic ranges for full anticoagulation: INR for Venous Thromboembolism ( ) INR INR for most patients with mech. valves ( ) INR

5 CBC, with DIFFERENTIAL (CBC, WITH DIFFERENTIAL) - Final result (02/09/2015 3:40 PM) The following orders were created for panel order CBC, WITH DIFFERENTIAL. Procedure Abnormality Status CBC AND AUTO DIFF[ ] Abnormal Final result MANUAL DIFFERENTIAL[ ] Abnormal Final result RBC MORPHOLOGY[ ] Final result Please view results for these tests on the individual orders. LIVER SET (LIVER SET (AST,ALT,BILI TOTAL,BILI DIRECT,ALK PHOS,ALB,PROT TOTAL)) - Final result (02/09/2015 3:40 PM) ALBUMIN, PLASMA (LAB) g/dl BILIRUBIN TOTAL mg/dl BILIRUBIN DIRECT < mg/dl ALK PHOS U/L AST(SGOT) U/L ALT (SGPT) U/L TOTAL PROTEIN, PLASMA (LAB) g/dl AST CMNT No Hemo BILI T CMNT No Hemo BILI D CMNT No Hemo FATTY ACID PROFILE, COMP (FATTY ACID PROFILE COMP, SERUM) - Final result (02/09/2015 3:40 PM) FATTY ACID INTERPRETATION SEE COMMENTS OCTANOIC ACID, C8: nmol/ml DECENOIC ACID, C10: nmol/ml DECANOIC ACID, C10: nmol/ml LAUROLEIC ACID, C12: nmol/ml LAURIC ACID, C12: nmol/ml TETRADECADIENOIC ACID, nmol/ml C14:2 MYRISTOLEIC ACID, C14: nmol/ml MYRISTIC ACID, C14: nmol/ml HEXADECADIENOIC ACID, C16: nmol/ml HEXADECENOIC ACID C16:1W nmol/ml PALMITOLEIC ACID, C16:1W nmol/ml PALMITIC ACID, C16: nmol/ml G-LINOLENIC ACID, C18:3W nmol/ml A-LINOLENIC ACID, C18:3W nmol/ml LINOLEIC ACID, C18:2W nmol/ml OLEIC ACID, C18:1W nmol/ml

6 VACCENIC ACID, C18:1W nmol/ml STEARIC ACID, C18: nmol/ml EPA, C20:5W nmol/ml ARACHIDONIC ACID, C20:4W nmol/ml MEAD ACID, C20:3W nmol/ml HOMO-G-LINOLENIC ACID, nmol/ml C20:3W6 ARACHIDIC ACID, C20: nmol/ml DHA, C22:6W nmol/ml DPA, C22:5W nmol/ml DPA, C22:5W nmol/ml DTA, C22:4W nmol/ml DOCOSENOIC ACID, C22: nmol/ml DOCOSANOIC ACID, C22: nmol/ml NERVONIC ACID, C24: nmol/ml TETRACOSANOIC ACID, C24: nmol/ml HEXACOSENOIC ACID, C26: nmol/ml HEXACOSANOIC ACID, C26: nmol/ml PRISTANIC ACID, C15:0(CH3) nmol/ml PHYTANIC ACID, C16:0(CH3) nmol/ml TRIENE/TETRAENE RATIO TOTAL SATURATED ACID mmol/l TOTAL MONUNSATURATED mmol/l ACID TOTAL POLYUNSATURATED mmol/l ACID TOTAL OMEGA(W) mmol/l TOTAL OMEGA(W) mmol/l TOTAL FATTY ACIDS mmol/l MAYO MEDICAL LAB-INTFC 200 FIRST ST. SOUTHWEST ROCHESTER, MN GGT (GGT, PLASMA) - Final result (02/09/2015 3:40 PM) GAMMA GLUTAMYL TRANS U/L CK (CK, PLASMA) - Final result (02/09/2015 3:40 PM) CK U/L

7 FAT,FECAL,QUALITATIVE (FAT QUALITATIVE, FECAL) - Final result (10/21/2014 4:17 PM) NEUTRAL FAT Normal Normal SPLIT FAT Normal Normal Stool - Rectum ARUP-ASSOC REG UNIV PTH - INTFC 500 CHIPETA WAY SALT LAKE CITY, UT PANCREATIC ELASTASE (PANCREATIC ELASTASE, STOOL) - Final result (10/21/2014 4:17 PM) PANCREATIC ELASTASE <50.0 ug E/g stool PES INTERPRETATION SEE COMMENTS Stool MAYO MEDICAL LAB-INTFC 200 FIRST ST. SOUTHWEST ROCHESTER, MN CBC AND AUTO DIFF - Final result (10/21/2014 3:54 PM) WHITE CELL COUNT K/cu mm RED CELL COUNT M/cu mm HEMOGLOBIN g/dl HEMATOCRIT % MCV fl MCHC g/dl RDW SD fl PLATELET COUNT K/cu mm MPV fl NRBC% % NRBC# K/cu mm MANUAL DIFFERENTIAL - Final result (10/21/2014 3:54 PM) NEUTROPHIL % % LYMPHOCYTE % % MONOCYTE % % EOSINOPHIL % % BASOPHIL % % IMMATURE GRANULOCYTE% % REACTIVE LYMPHS % %

8 NEUTROPHIL # K/cu mm LYMPHOCYTE # K/cu mm MONOCYTE # K/cu mm EOSINOPHIL # K/cu mm BASOPHIL # K/cu mm IMMATURE GRANULOCYTE# K/cu mm REACTIVE LYMPHS # 1.03 K/cu mm Immature Granulocytes (IG) include metamyelocytes, myelocytes and promyelocytes. included in the IG count. Bands are included in the neutrophil count. Bands are not INR - Final result (10/21/2014 3:54 PM) INR INR INR Therapeutic ranges for full anticoagulation: INR for Venous Thromboembolism ( ) INR INR for most patients with mech. valves ( ) INR CBC, with DIFFERENTIAL (CBC, WITH DIFFERENTIAL) - Final result (10/21/2014 3:54 PM) The following orders were created for panel order CBC, WITH DIFFERENTIAL. Procedure Abnormality Status CBC AND AUTO DIFF[ ] Abnormal Final result MANUAL DIFFERENTIAL[ ] Abnormal Final result Please view results for these tests on the individual orders. VITAMIN D, 25-HYDROXY (VITAMIN D, 25-HYDROXY, SERUM) - Final result (10/21/2014 3:54 PM) VITAMIN D 25 HYDROXY ng/ml OHSU LABORATORY SERVICES, SPECIAL IMM + COAG

9 REFERENCE INTERVAL: Vitamin D, 25-Hydroxy 0-17years: Deficiency: less than 20 ng/ml Optimum level: greater than or equal to 20 ng/ml* *(Wagner CL et al. Pediatrics 2008; 122: ) 18 years and older: Deficiency: less than 20 ng/ml Insufficiency: ng/ml Optimum Level: ng/ml High: ng/ml Toxic: Greater than 150 ng/ml This assay accurately quantifies the sum of Vitamin D3 25-hydroxy and Vitamin D2, 25-hydroxy. Reference range change effective 7/25/2013. COMP METABOLIC SET (COMPLETE METABOLIC SET (NA,K,CL,CO2,BUN,CREAT,GLUC,CA,AST,ALT,BILI TOTAL,ALK PHOS,ALB,PROT TOTAL)) - Final result (10/21/2014 3:54 PM) GLUCOSE, PLASMA (LAB) mg/dl BUN, PLASMA (LAB) mg/dl CREATININE PLASMA (LAB) mg/dl SODIUM, PLASMA (LAB) mmol/l POTASSIUM, PLASMA (LAB) mmol/l CHLORIDE, PLASMA (LAB) mmol/l TOTAL CO2, PLASMA (LAB) mmol/l CALCIUM, PLASMA (LAB) mg/dl BILIRUBIN TOTAL mg/dl TOTAL PROTEIN, PLASMA (LAB) g/dl ALBUMIN, PLASMA (LAB) g/dl ALK PHOS U/L AST(SGOT) U/L ALT (SGPT) U/L ANION GAP(ALB CORRECTED) mmol/l POTASSIUM CMNT No Hemo BILI T CMNT No Hemo AST CMNT No Hemo ANION GAP 11 mmol/l GGT (GGT, PLASMA) - Final result (10/21/2014 3:54 PM) GAMMA GLUTAMYL TRANS U/L

10 Visit Diagnoses - as of 04/27/2017 Diagnosis Start Date Abnormal stools 10/21/2014 Exocrine pancreatic insufficiency 10/21/2014 Restricted diet 10/21/2014 Liver cirrhosis (HCC) 10/21/2014 History of liver failure 10/21/2014 Stool fat increased 10/21/2014 Abnormal laboratory test 2/9/2015 Elevated transaminase level 2/9/2015 Micronodular cirrhosis of liver (HCC) 2/9/2015 Dietary restriction 2/9/2015 Furuncle of neck 2/9/2015 Abnormal laboratory test 2/9/2015 Liver dysfunction 2/9/2015 Document Information Primary Care Provider Peggy M Kibbel NP (Oct. 13, Present) (Work) (Fax) OVERLAKE OB GYN TH AVE N E STE 201 BELLEVUE, WA Document Coverage Dates Sep. 16, Apr. 27, 2017 Custodian Organization Oregon Health & Science University (Work) 3181 S.W. Sam Jackson Park Rd. Portland, OR 97239

11